From Undruggable to Therapeutic: Metadichol Selectively Modulates Stress-Responsive Housekeeping Genes in Human Peripheral Blood Mononuclear Cells and Six Cancer Cell Lines

Background: Housekeeping genes (HKGs) maintain essential cellular functions-metabolism, protein synthesis, and structural integrity-and were long considered "undruggable." However, cancer cells exhibit altered HKG dependence, particularly in glycolysis (Warburg effect) and protein synthesis, creating therapeutic openings. Single-cell RNA sequencing from the Human Protein Atlas confirms ubiquitous HKG expression across 557 human cell-type clusters. Metadichol, a nanoemulsion of policosanols, acts as a "master conductor" of gene regulation-modulating all 49 nuclear receptors, sirtuins (SIRT1-7), Yamanaka factors, and tumor suppressors. Unlike toxic enzyme inhibitors, it achieves bidirectional regulation at picomolar-nanomolar concentrations with a favorable safety profile (LD50 >5000 mg/kg). Methods: PBMCs isolated from fresh human blood were treated with Metadichol (0.1 pg/mL-100 ng/mL) for 24 hours. Nineteen HKGs across six functional categories-cytoskeletal (ACTB, TUBB), translation (EIF1, EIF2S2, EIF4A2, EIF5, RPLP0), heat shock (HSPA5, HSPA9, CANX), stress-response transcription factors (ATF4, HIF1A), signaling (PTPRO, PTMS, PTMA, B2M), and metabolic enzymes (GAPDH, HPRT1, FDFT1)-were quantified by qRT-PCR (SYBR Green), normalized to GAPDH via the 2-??Cq method. The identical panel and dose range were then applied to six cancer cell lines: U87MG (glioblastoma), HCT116 (colorectal), HeLa (cervical), HepG2 (hepatocellular), FaDu (hypopharyngeal), and A549 (lung). Results: Significant modulation occurred at concentrations as low as 0.1 pg/mL. ATF4 showed robust upregulation (4.06-fold at 1 pg/mL, P<0.05), and the tumor suppressor PTPRO the highest induction (6.02-fold at 100 pg/mL, P<0.001) with a triphasic dose-response. HIF1A displayed biphasic regulation, while ACTB and TUBB remained stable, validating selective targeting. In cancer lines, a conserved pan-cancer signature-ATF4 (mean 3.05x), PTPRO (mean 2.75x), HSPA5, HSPA9, PTMS, and HIF1A-was up-regulated across all six, with references stable. Notably, HIF1A was induced in every line (mean 3.09x, up to 4.69x)-reversing its PBMC suppression-and strong PBMC B2M induction was blunted in tumors (mean 1.10x), consistent with tumor-intrinsic MHC-I repression. Conclusions: Metadichol selectively modulates stress-responsive housekeeping genes while preserving core cellular machinery. HKG modulation represents a unifying upstream mechanism, since master regulators (ATF4, HIF1A, EIF factors) each control hundreds of downstream targets-explaining how picomolar concentrations produce broad therapeutic effects. This positions Metadichol as a first-in-class compound achieving comprehensive housekeeping gene modulation through a physiological, nuclear receptor-mediated mechanism.